How should I interpret an interferon gamma release assay result for tuberculosis infection?

Thorax

Volumn 68, Issue 3, 2013, Pages 298-301

  Abubakar, Ibrahim ^a   Stagg, Helen Ruth ^a   Whitworth, Hilary ^b   Lalvani, Ajit ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELLULAR IMMUNITY; CLINICAL PRACTICE; CLINICAL RESEARCH; DIAGNOSTIC TEST; DISEASE COURSE; FALSE NEGATIVE RESULT; HUMAN; IMMUNOCOMPROMISED PATIENT; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; LONGITUDINAL STUDY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS;

EID: 84873637794     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2013-203247     Document Type: Article

References (30)

1. World Health Organization (WHO). Global tuberculosis control 2011. Geneva: WHO, 2012. http://www.who.int/tb/publications/global-report/en/index. html (accessed 25th January 2013).
2. Dye C, Scheele S, Dolin P, et al. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999; 282: 677-86.
3. Abubakar I, Lipman M, Anderson C, et al. Tuberculosis in the UK-time to regain control. BMJ 2011; 343: d4281.
4. Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibl Tuberc 1970; 26: 28-106.
5. Pai M, Riley LW, Colford JM. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004; 4: 761-76.
6. National Institute for Health and Clinical Excellence (NICE). Clinical diagnosis and management of tuberculosis, and measures for its prevention and control: IGRA partial update. London: NICE2011.
7. Mazurek GH, Jereb J, Vernon A, et al. Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection-United States, 2010. MMWR Recomm Rep 2010; 59: 1-25.
8. Rangaka MX, Wilkinson KA, Glynn JR, et al. Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12: 45-55.
9. Diel R, Loddenkemper R, Nienhaus A. Predictive value of interferon-gamma release assays and tuberculin skin testing for predicting progression from latent TB infection to disease state: a meta-analysis. Chest 2012; 142: 63-75.
10. Abubakar I, Griffiths C, Ormerod L. Diagnosis of active and latent tuberculosis: summary of updated NICE guidelines. BMJ (Clin Res Ed) 2012; 345: e6828.
11. Haldar P, Thuraisingam H, Patel H, et al. Single-step QuantiFERON screening of adult contacts: a prospective cohort study of tuberculosis risk. Thorax Published Online First: 6 September 2012. doi: 10.1136/thoraxjnl-2011- 200956
12. Hinks TSC, Dosanjh DPS, Innes JA, et al. Frequencies of region of difference 1 antigen-specific but not purified protein derivative-specific gamma interferon-secreting T cells correlate with the presence of tuberculosis disease but do not distinguish recent from remote latent infections. Infect Immun 2009; 77: 5486-95.
13. Bradshaw L, Davies E, Devine M, et al. The role of the interferon gamma release assay in assessing recent tuberculosis transmission in a hospital incident. PLoS ONE. 2011; 6: e20770.
14. Lienhardt C, Fielding K, Hane AA, et al. Evaluation of the prognostic value of IFN-gamma release assay and tuberculin skin test in household contacts of infectious tuberculosis cases in Senegal. PLoS ONE 2010; 5: e10508.
15. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146: 340-54.
16. Pai M, Joshi R, Dogra S, et al. Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med 2006; 174: 349-55.
17. Dosanjh DP, Hinks TS, Innes JA, et al. Improved diagnostic evaluation of suspected tuberculosis. Ann Intern Med 2008; 148: 325-36.
18. Sester M, Sotgiu G, Lange C, et al. Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J 2011; 37: 100-11.
19. Mandalakas AM, Detjen AK, Hesseling AC, et al. Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis 2011; 15: 1018-32.
20. National Institute for Health and Clinical Excellence. Tuberculosis: Clinical diagnosis and management of tuberculosis, and measures for its prevention and control. Clinical Guideline 117. London: NICE, 2011. http://guidance.nice.org.uk/CG117 (accessed 25th January 2013).
21. Millington KA, Fortune SM, Low J, et al. Rv3615c is a highly immunodominant RD1 (Region of Difference 1)-dependent secreted antigen specific for Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 2011; 108: 5730-5.
22. Casey R, Blumenkrantz D, Millington K, et al. Enumeration of functional T-cell subsets by fluorescence-immunospot defines signatures of pathogen burden in tuberculosis. PLoS One 2010; 5: e15619.
23. Harari A, Rozot V, Enders FB, et al. Dominant TNF-α + Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease. Nat Med 2011; 17: 372-6.
24. Whitworth HS, Scott M, Connell DW, et al. IGRAs - The gateway to T cell based TB diagnosis. Methods Published Online First: 3 Jan 2013. pii: S1046-2023(12)00326-X.
25. Lalvani A, Pareek M. Immigrant screening for TB: a missed opportunity to improve TB control in the United Kingdom. Pathog Glob Health 2012; 106: 5-7.
26. Pareek M, Abubakar I, White PJ, et al. UK immigrant screening is inversely related to regional tuberculosis burden. Thorax 2011; 66: 1010.
27. Pareek M, Watson JP, Ormerod LP, et al. Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis. Lancet Infect Dis 2011; 11: 435-44.
28. Pareek M, Bond M, Shorey J, et al. Community-based evaluation of immigrant tuberculosis screening using interferon γ release assays and tuberculin skin testing: observational study and economic analysis. Published Online First: 12 June 2012. doi: 10.1136/thoraxjnl-2011-201542
29. Hardy AB, Varma R, Collyns T, et al. Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries. Thorax 2010; 65: 178-80.
30. Stagg HR, Jones J, Bickler G, et al. Poor uptake of primary healthcare registration among recent entrants to the UK: a retrospective cohort study. BMJ Open 2012; 2.